Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
In the Phase 3 TRIUMPH-4 trial, participants on the highest dose (12 mg) lost an average of 28.7% of their body weight over 68 weeks
Lever JR, Murphy AP, Duffield R, Fullagar HHK
PMID 10217035
Patients with a documented history of chronic pancreatitis or more than one episode of acute pancreatitis should not use GLP-1 agents outside of a setting where a gastroenterologist is involved in the treatment plan
Bring a list of your recent TSH results if possible, as this helps your doctor assess your current thyroid control and establish a baseline for future monitoring
US$ 23.08
US$ 22.94
